首页 › 基金 › Ghisallo Capital Management LLC › NTLA

Ghisallo Capital Management LLC 对 NTLA 的持仓历史

INTELLIA THERAPEUTICS INC · 医疗保健

Ghisallo Capital Management LLC 在 Q3 2026 的 13F 申报中披露持有 NTLA(INTELLIA THERAPEUTICS INC)1,000,000 股,市值约 US$12.1M,约占其申报组合的 0.28%,在其申报持仓中市值排名第 43 位。 Ghisallo Capital Management LLC 最近 2 个申报季度中有 2 个季度披露了 NTLA 持仓,最早可追溯至 Q2 2026。

最新持仓 (Q3 2026)1.00M 股
申报持仓市值$12.06M
组合权重0.28%
首次申报Q2 2026
最近变动减持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Ghisallo Capital Management LLC 对 NTLA 的持仓演变

Ghisallo Capital Management LLC 于 Q2 2026 首次披露 NTLA 持仓:1,200,000 股(约 US$20.3M)。 在 2 次申报中,Ghisallo Capital Management LLC 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 1,000,000 股、市值约 US$12.1M,环比减持 -200,000 股。。

逐季持仓明细

季度股数金额变化
Q2 2026 1.20M $20.30M 新进
Q3 2026 1.00M $12.06M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 NTLA 与 13F 数据

NTLA(INTELLIA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 30 只申报持有 NTLA,申报仓位最大的包括:方舟投资 (US$192.1M), RA CAPITAL MANAGEMENT, L.P. (US$76.6M), REGENERON PHARMACEUTICALS, INC. (US$44.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NTLA 的基金

查看 NTLA 的全部基金持有人 →

常见问题

How long has Ghisallo Capital Management LLC held NTLA?

Ghisallo Capital Management LLC has disclosed NTLA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Ghisallo Capital Management LLC's current position in NTLA?

As of Q3 2026, Ghisallo Capital Management LLC holds 1.00M shares of NTLA (INTELLIA THERAPEUTICS INC), valued at $12.06M, representing 0.28% of its reported portfolio and ranking #43.

Has Ghisallo Capital Management LLC been buying or selling NTLA?

In the latest 13F filing (Q3 2026), Ghisallo Capital Management LLC reduced its position in NTLA.

Which other funds hold NTLA?

Other major institutional holders of NTLA include 方舟投资, RA CAPITAL MANAGEMENT, L.P., REGENERON PHARMACEUTICALS, INC., among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.